GENEVA, March 26 -- SENTRIMED, INC. (107 Gilbreth ParkwayMullica Hill, NJ 08062) filed a patent application (PCT/US2024/046332) for "SOLUBLE RECOMBINANT HUMAN PODOPLANIN RECEPTOR" on Sep 12, 2024. With publication no. WO/2025/059266, the details related to the patent application was published on Mar 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GOLDBERG, Gary S. (c/o Sentrimend, Inc.107 Gilbreth ParkwayMullica Hill, NJ 08062), HAUSTRAETE, Jurgen (c/o Sentrimend, Inc.107 Gilbreth ParkwayMullica Hill, NJ 08062)
Abstract:
Disclosed is a composition of matter and a method for using that...